| Serial Number | 87449741 |
| Word Mark | ALUNBRIG 1POINT |
| Filing Date | Monday, May 15, 2017 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Tuesday, January 7, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 30, 2019 |
| Indication of Colors claimed | The color(s) aqua, gray, yellow, white, and red-orange is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a succession of seven various sized arcs, three in yellow, two in aqua, and two in red-orange, appearing above the word "ALUNBRIG" in stylized aqua lettering and to the right, a thin light grey vertical line, followed by the number "1" in white, appearing in the overlapping area of two triangles, one in grey and one in shades of aqua, being partially obstructed by the letter "P" in the word "POINT", in aqua stylized lettering, to the right of the triangles. All white areas other than the number "1" are background and/or transparent areas and are not part of the mark. |
| Goods and Services | Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services |
| Goods and Services | Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information |
| Goods and Services | Providing medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders |
| Goods and Services | Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders |
| Pseudo Mark | ALUNBRIG ONE POINT |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, January 7, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, January 7, 2020 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, January 7, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Tuesday, January 7, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Millennium Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Millennium Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Tuesday, January 7, 2020 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Tuesday, January 7, 2020 | ABANDONMENT - AFTER PUBLICATION |
| Monday, January 6, 2020 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Monday, September 23, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, September 23, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 24, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, August 29, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 30, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 10, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 26, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, June 21, 2019 | ASSIGNED TO LIE |
| Monday, June 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 7, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 7, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 7, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 5, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 5, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 5, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 5, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, January 22, 2019 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, December 20, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 22, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 20, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 20, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 20, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, June 1, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 31, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 31, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 30, 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, May 30, 2018 | PRIORITY ACTION E-MAILED |
| Wednesday, May 30, 2018 | PRIORITY ACTION WRITTEN |
| Saturday, May 19, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 18, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 18, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, November 18, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, November 18, 2017 | NON-FINAL ACTION E-MAILED |
| Saturday, November 18, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 15, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 14, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 14, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 17, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 17, 2017 | NON-FINAL ACTION E-MAILED |
| Thursday, August 17, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 9, 2017 | ASSIGNED TO EXAMINER |
| Saturday, May 20, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, May 19, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 18, 2017 | NEW APPLICATION ENTERED IN TRAM |